The US Food and Drug Administration and Centers for Disease Control and Prevention are likely to soon permit the administration of an additional COVID-19 vaccine dose to immunocompromised individuals, according to recent reports, but for a variety of reasons they may steer clear of referring to the additional shots as a booster.
US media reports on 6 August indicated that the FDA could authorize the extra shots within days or weeks and that a 13 August CDC Advisory Committee on Immunization Practices...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?